DD128555A5 - Disubstituierte phenolaether des 3-amino-2-hydroxypropans,verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel - Google Patents
Disubstituierte phenolaether des 3-amino-2-hydroxypropans,verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittelInfo
- Publication number
- DD128555A5 DD128555A5 DD7600195393A DD19539376A DD128555A5 DD 128555 A5 DD128555 A5 DD 128555A5 DD 7600195393 A DD7600195393 A DD 7600195393A DD 19539376 A DD19539376 A DD 19539376A DD 128555 A5 DD128555 A5 DD 128555A5
- Authority
- DD
- German Democratic Republic
- Prior art keywords
- hydroxypropano
- medicaments
- amino
- preparation
- phenol ethers
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- 150000008379 phenol ethers Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/34—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by halogen atoms, by trihalomethyl, nitro or nitroso groups, or by singly-bound oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/04—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C217/28—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines
- C07C217/30—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring
- C07C217/32—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted
- C07C217/36—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having one amino group and at least two singly-bound oxygen atoms, with at least one being part of an etherified hydroxy group, bound to the carbon skeleton, e.g. ethers of polyhydroxy amines having the oxygen atom of at least one of the etherified hydroxy groups further bound to a carbon atom of a six-membered aromatic ring the six-membered aromatic ring or condensed ring system containing that ring being further substituted by carbon atoms having at least two bonds to oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/18—Fluorenes; Hydrogenated fluorenes
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19752547524 DE2547524A1 (de) | 1975-10-23 | 1975-10-23 | Disubstituierte phenolaether des 3-amino-2-hydroxypropans, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DD128555A5 true DD128555A5 (de) | 1977-11-23 |
Family
ID=5959934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD7600195393A DD128555A5 (de) | 1975-10-23 | 1976-10-21 | Disubstituierte phenolaether des 3-amino-2-hydroxypropans,verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
Country Status (29)
Country | Link |
---|---|
US (1) | US4110472A (sv) |
JP (1) | JPS5935387B2 (sv) |
AT (2) | AT345792B (sv) |
AU (1) | AU502167B2 (sv) |
BE (1) | BE847541A (sv) |
BG (2) | BG31796A3 (sv) |
CA (1) | CA1085417A (sv) |
CH (2) | CH623562A5 (sv) |
CS (2) | CS191322B2 (sv) |
DD (1) | DD128555A5 (sv) |
DE (1) | DE2547524A1 (sv) |
DK (1) | DK480376A (sv) |
ES (1) | ES452616A1 (sv) |
FI (1) | FI67075C (sv) |
FR (1) | FR2328458A1 (sv) |
GB (1) | GB1497500A (sv) |
GR (1) | GR61598B (sv) |
HU (1) | HU174097B (sv) |
IE (1) | IE43745B1 (sv) |
IL (1) | IL50732A (sv) |
LU (1) | LU76057A1 (sv) |
NL (1) | NL7611683A (sv) |
NO (1) | NO143844C (sv) |
PL (2) | PL110002B1 (sv) |
PT (1) | PT65737B (sv) |
RO (1) | RO76883A (sv) |
SE (1) | SE432926B (sv) |
SU (2) | SU639443A3 (sv) |
ZA (1) | ZA766303B (sv) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0333938A1 (en) * | 1987-12-01 | 1989-09-27 | ZAMBON GROUP S.p.A. | 2-Hydroxy-3-aryloxy-propylamine derivatives having cardiovascular activity |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5541204A (en) * | 1994-12-02 | 1996-07-30 | Bristol-Myers Squibb Company | Aryloxypropanolamine β 3 adrenergic agonists |
US20090170841A1 (en) | 2007-04-20 | 2009-07-02 | Acucela Inc. | Styrenyl Derivative Compounds for Treating Ophthalmic Diseases and Disorders |
FR3030514A1 (fr) * | 2014-12-18 | 2016-06-24 | Centre De Coop Int En Rech Agronomique Pour Le Dev (Cirad) | Dimeres polyaromatiques |
EP3144289A1 (en) * | 2015-09-16 | 2017-03-22 | Evonik Technochemie GmbH | [(2-ethoxy-5-trans-1-propen-1-yl)-phenoxyl]-terminated compounds |
KR20190096949A (ko) | 2016-10-05 | 2019-08-20 | 유니버시티 오브 피츠버그 - 오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션 | 소분자 ampk 활성화제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3758583A (en) * | 1971-01-21 | 1973-09-11 | Syntex Corp | 2-(2-hydroxy-3-aminopropyl-1-yloxy)-1,6-dilfuoro-and-1,6-methano-{8 10{9 annulenes and the salts thereof |
-
1975
- 1975-10-23 DE DE19752547524 patent/DE2547524A1/de not_active Withdrawn
-
1976
- 1976-10-08 NO NO763442A patent/NO143844C/no unknown
- 1976-10-13 US US05/732,118 patent/US4110472A/en not_active Expired - Lifetime
- 1976-10-18 CH CH1318976A patent/CH623562A5/de not_active IP Right Cessation
- 1976-10-18 SU SU762413401A patent/SU639443A3/ru active
- 1976-10-19 AU AU18797/76A patent/AU502167B2/en not_active Expired
- 1976-10-19 BG BG7635324A patent/BG31796A3/xx unknown
- 1976-10-19 BG BG7634473A patent/BG27732A3/xx unknown
- 1976-10-20 IL IL50732A patent/IL50732A/xx unknown
- 1976-10-20 PT PT65737A patent/PT65737B/pt unknown
- 1976-10-21 NL NL7611683A patent/NL7611683A/xx not_active Application Discontinuation
- 1976-10-21 DD DD7600195393A patent/DD128555A5/xx unknown
- 1976-10-21 GB GB43725/76A patent/GB1497500A/en not_active Expired
- 1976-10-21 JP JP51125582A patent/JPS5935387B2/ja not_active Expired
- 1976-10-21 SE SE7611686A patent/SE432926B/sv unknown
- 1976-10-21 FI FI763010A patent/FI67075C/fi not_active IP Right Cessation
- 1976-10-21 HU HU76BA3468A patent/HU174097B/hu unknown
- 1976-10-21 AT AT606377A patent/AT345792B/de not_active IP Right Cessation
- 1976-10-21 AT AT784476A patent/AT344682B/de not_active IP Right Cessation
- 1976-10-22 RO RO7696832A patent/RO76883A/ro unknown
- 1976-10-22 PL PL1976213281A patent/PL110002B1/pl unknown
- 1976-10-22 ES ES452616A patent/ES452616A1/es not_active Expired
- 1976-10-22 CS CS766837A patent/CS191322B2/cs unknown
- 1976-10-22 PL PL1976193206A patent/PL110007B1/pl unknown
- 1976-10-22 BE BE171708A patent/BE847541A/xx not_active IP Right Cessation
- 1976-10-22 DK DK480376A patent/DK480376A/da not_active Application Discontinuation
- 1976-10-22 IE IE2332/76A patent/IE43745B1/en unknown
- 1976-10-22 CS CS777809A patent/CS191344B2/cs unknown
- 1976-10-22 GR GR51997A patent/GR61598B/el unknown
- 1976-10-22 FR FR7631948A patent/FR2328458A1/fr active Granted
- 1976-10-22 CA CA263,964A patent/CA1085417A/en not_active Expired
- 1976-10-22 LU LU76057A patent/LU76057A1/xx unknown
- 1976-10-22 ZA ZA766303A patent/ZA766303B/xx unknown
-
1977
- 1977-07-15 SU SU772502200A patent/SU664559A3/ru active
-
1980
- 1980-09-08 CH CH672680A patent/CH630058A5/de not_active IP Right Cessation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0333938A1 (en) * | 1987-12-01 | 1989-09-27 | ZAMBON GROUP S.p.A. | 2-Hydroxy-3-aryloxy-propylamine derivatives having cardiovascular activity |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE851T1 (de) | Hydroxyethyl-azole, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel. | |
ATE1636T1 (de) | Antiperspirante zusammensetzung und verfahren zu ihrer herstellung und verwendung. | |
DD140110A1 (de) | Katalysatorzusammensetzungen,verfahren zu ihrer herstellung und ihre verwendung | |
DE19875010I2 (de) | Acetamidderivate Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel | |
ATE8892T1 (de) | Substituierte azabicyclooctancarboxylsaeure, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
LU78804A1 (de) | N-substituierte w-aminoalkanoyl-w-aminoalkansaeuren,ihre verwendung und verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel | |
PT67718A (de) | Tetrahydrofuranaether-derivate,verfahren zu ihrer herstellung sowie ihre verwendung als herbizide | |
PT68006A (de) | Azolylather-derivate verfahren zu ihrer herstellung sowie ihre verwendung als fungizide | |
ATE5319T1 (de) | Imidazolylvinylether, verfahren zu deren herstellung, deren verwendung und diese ether enthaltende arzneimittel und pflanzenschutzmittel. | |
ATE1360T1 (de) | Fungizide mittel, verfahren zu ihrer herstellung sowie ihre verwendung als fungizide. | |
ATE5257T1 (de) | Tricyclische aether, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel. | |
PT67442A (de) | Thiazolylzimtsaeurenitrile,schaedlingsbekaempfungsmittel enthaltende,diese verbindungen sowie verfahren zu ihrer herstellung | |
DD128555A5 (de) | Disubstituierte phenolaether des 3-amino-2-hydroxypropans,verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel | |
ATE10634T1 (de) | Pyrazoloindazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitung. | |
ATE15196T1 (de) | N-substituierte 2-pyridylindole, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung. | |
PT65521B (de) | "n-te trahydrofurfuryl-noroxymorphone deren saureadditionssalze diese enthaltende arzneimittel sowie verfahren zu ihrer herstellung | |
PT68404A (de) | 4-hydroxy-2-benzimidazolinon-derivate verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel | |
LU78625A1 (de) | Substituierte 1-phenyl-2-pyrrolidin-2-yl-ethanole,verfahren zu ihrer herstellung,ihre verwendung und sie enthaltende arzneimittel | |
LU79168A1 (de) | Benzylpyrimidine,verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
PT65491B (de) | Vinylthionophosphorsaureester verfahren zu ihrer herstellung sowie ihre verwendung als insektizide und akarizide | |
ATE2744T1 (de) | N,n-dimethyl-o-pyrimidinyl-carbaminsaeureester, verfahren zu ihrer herstellung sowie ihre verwendung als schaedlingsbekaempfungsmittel. | |
PT65578A (de) | N-(1,2,4-triazin-5-on-4-yl)-glycin-derivate,verfahren zu ihrer herstellung sowie ihre verwendung als herbizide | |
ATE3422T1 (de) | Tetrahydrochinolinderivate, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende pharmazeutische zubereitungen. | |
PT70934A (de) | Substituierte n-allyl-acetanilide verfahren zu ihrer herstellung sowie ihre verwendung als fungizide | |
PT69020A (de) | Carbamoyl-triazolyl-o,n-acetale, verfahren zu ihrer herstellung und ihre verwendung als fungizide |